22h
Hosted on MSNJ&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ resultsThe company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results